Previous close | 43.82 |
Open | 44.00 |
Bid | 43.91 x 900 |
Ask | 44.03 x 3100 |
Day's range | 43.83 - 44.21 |
52-week range | 39.07 - 46.86 |
Volume | |
Avg. volume | 12,900,491 |
Market cap | 75.541B |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | 9.20 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.92 (8.95%) |
Ex-dividend date | 22 Mar 2024 |
1y target est | N/A |
Artsana, a maker of child car booster seats, last year agreed to settle claims that it had misled customers about how to use its products, offering $50 to people who had bought Chicco-brand seats. The company, which did not admit wrongdoing in the settlement, knew it sold roughly 875,000 such seats, yet court records show that by the end of October it had received more than 3.3 million claims for payment. Faced with a wave of questionable claims, Artsana reversed itself and urged the court not to approve the settlement it had negotiated to end the litigation.
While ethical investors may opt to steer clear, top tobacco stock Altria Group currently boasts the highest dividend in the S&P 500 with a smoking-hot yield. Altria, best known for its iconic Marlboro cigarettes, was formed from a 2007 spinoff from Philip Morris. Altria took control of U.S. tobacco interests, prioritizing dividend growth and share buybacks, while Philip Morris focused on the international market.
Altria (MO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.